Amber Tx logo.png
Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval
June 10, 2024 03:00 ET | Amber Therapeutics
US approval would make Amber-UI the first fully implantable adaptive neuromodulation therapy for women with mixed urinary incontinence (MUI)By targeting the pudendal nerve, Amber-UI has the unique...
Amber Theraputics Brand Mark BURNT ORANGE.png
Amber Therapeutics announces positive preliminary results from its first-in-human investigation of Amber-UI, its new adaptive implanted pudendal neuromodulation system for urinary incontinence
February 27, 2024 09:00 ET | Amber Therapeutics
Key initial results from AURA-2 study highlight good safety and scalability of Amber-UI therapy A strong efficacy signal was seen in the form of complete resolution of incontinence episodes six months...
EG+427+-+Main+logo+-+Full+color.png
EG 427 announces final Series A closing, achieving €18 million in total funds raised
July 13, 2023 02:00 ET | EG 427
Paris, France, 13 July, 2023 – EG 427, a biotechnology company leading the development of pinpoint DNA medicine solutions, announces today the final closing of a Series A financing. EG 427 raised an...
MicrosoftTeams-image (5).png
Urinary Catheters Market Value to expand at a 4.5% CAGR from 2021 to 2028, reaching USD 5.1 billion: TMR Report
May 05, 2023 14:30 ET | Transparency Market Research
Wilmington, Delaware, United States, May 06, 2023 (GLOBE NEWSWIRE) -- The global urinary catheters market was estimated at a market value of USD 3.1 billion in 2020. During the forecast years of...
FINAL lOGO.png
Rising Cases of Urinary Tract Infections Propel Urinary Catheters Market to US$ 3.2 billion by 2033, Says Persistence Market Research
April 06, 2023 11:10 ET | Persistence Market Research
New York, April 06, 2023 (GLOBE NEWSWIRE) -- The Urinary Catheters Market was projected to grow at a CAGR of 5.3% from its 2022 revenue of roughly US$ 1.8 billion to an expected value of US$ 3.2...
logo 600X600.png
Urinary Catheters Market to Surpass US$ 8,157.8 Million by 2030, Says Coherent Market Insights (CMI)
February 21, 2023 09:30 ET | CMI
Burlingame, Feb. 21, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global urinary catheters market is estimated to be valued at US$ 5,293.6 in 2022 and is expected to exhibit a...
22157.jpg
Worldwide Urinary Incontinence Industry Report 2022 - Featuring Coloplast, Contura, ConvaTec, Degania Medical and DeRoyal Among Others
December 30, 2022 05:48 ET | Research and Markets
Dublin, Dec. 30, 2022 (GLOBE NEWSWIRE) -- The "Urinary Incontinence Market Report with COVID Impact - Global - 2022 - 2028 - MedCore" report has been added to ResearchAndMarkets.com's offering. ...
Sm-logo-resized.jpg.png
Sacral Nerve Stimulation Market is expected to reach $8.22 Billion by 2028, With a CAGR of 14.07 %
June 02, 2022 10:59 ET | STRATEGIC MARKET RESEARCH LLP
New York, United States, June 02, 2022 (GLOBE NEWSWIRE) -- Sacral nerve stimulation (SNS) is known as a medical & electrical stimulation therapy that involves the implantation of a programmable...
SCONE Therapy
SpineX Announces Successful First in Human Study Results of SCONE therapy to treat Urge Urinary Incontinence
March 23, 2022 13:00 ET | SpineX
SpineX’s Proprietary non-surgical SCONE™ Device Offers New Hope millions of individuals suffering from overactive bladder LOS ANGELES, March 23, 2022 (GLOBE NEWSWIRE) -- SpineX, Inc., an early...
AMR Logo.png
Intermittent Catheters Market Forecasted to Reach $3.31 Billion by 2030, Says AMR
March 16, 2022 11:24 ET | Allied Market Research
Portland, OR, March 16, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global intermittent catheters market was estimated at $2.03 billion in 2020 and is...